$CAMXI like what I see and will try going long here, but remember that it has tested this level a few times = weaker support.
stopploss = 580 (dayclose under)
Camurus AB
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.34 USD
79.59 M USD
245.11 M USD
36.81 M
About Camurus AB
Sector
Industry
CEO
Sven Fredrik Tiberg
Website
Headquarters
Lund
Founded
2004
IPO date
Dec 3, 2015
Identifiers
2
ISIN SE0007692850
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Related stocks
CAMARUS thoughtsSo looking at Camarus there are some mixed signals currently, so it's best to wait and see how things will pan out.
We can however already look at some different scenarios to prepare ourselves.
Green scenario:
CAMARUS broke above resistance, retested this resistance and turned it into support. Whil
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MEUH
Amundi Core Stoxx Europe 600 -UCITS ETF HEDGED- CapitalisationWeight
0.02%
Market value
4.54 M
USD
STXH
Amundi Index Solutions SICAV - Amundi Core Stoxx Europe 600 UCITS ETF Monthly Hedged to EUR - Dist- DistributionWeight
0.02%
Market value
4.54 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of CAMRF is 57.85 USD — it has decreased by −18.52% in the past 24 hours. Watch Camurus AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Camurus AB stocks are traded under the ticker CAMRF.
CAMRF stock has fallen by −18.52% compared to the previous week, the month change is a −18.52% fall, over the last year Camurus AB has showed a 13.51% increase.
We've gathered analysts' opinions on Camurus AB future price: according to them, CAMRF price has a max estimate of 111.60 USD and a min estimate of 73.66 USD. Watch CAMRF chart and read a more detailed Camurus AB stock forecast: see what analysts think of Camurus AB and suggest that you do with its stocks.
CAMRF reached its all-time high on Jun 4, 2025 with the price of 71.07 USD, and its all-time low was 7.48 USD and was reached on Mar 13, 2020. View more price dynamics on CAMRF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CAMRF stock is 22.73% volatile and has beta coefficient of 0.72. Track Camurus AB stock price on the chart and check out the list of the most volatile stocks — is Camurus AB there?
Today Camurus AB has the market capitalization of 3.37 B, it has increased by 1.52% over the last week.
Yes, you can track Camurus AB financials in yearly and quarterly reports right on TradingView.
Camurus AB is going to release the next earnings report on May 12, 2026. Keep track of upcoming events with our Earnings Calendar.
CAMRF earnings for the last quarter are 0.18 USD per share, whereas the estimation was 0.26 USD resulting in a −29.45% surprise. The estimated earnings for the next quarter are 0.44 USD per share. See more details about Camurus AB earnings.
Camurus AB revenue for the last quarter amounts to 50.25 M USD, despite the estimated figure of 65.54 M USD. In the next quarter, revenue is expected to reach 74.57 M USD.
CAMRF net income for the last quarter is 10.92 M USD, while the quarter before that showed 20.40 M USD of net income which accounts for −46.50% change. Track more Camurus AB financial stats to get the full picture.
No, CAMRF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 268 employees. See our rating of the largest employees — is Camurus AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Camurus AB EBITDA is 98.37 M USD, and current EBITDA margin is 40.13%. See more stats in Camurus AB financial statements.
Like other stocks, CAMRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Camurus AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Camurus AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Camurus AB stock shows the neutral signal. See more of Camurus AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.